Skip to main content
. 2022 Nov 16;53(4):405–416. doi: 10.1111/cea.14251

FIGURE 5.

FIGURE 5

PCBAT with peanut allergen extracts on peanut allergic subjects validated with oral peanut challenge. Of the 30 peanut allergic subjects performed with PCBAT, 15 underwent oral food challenge. Scatter plot showed the relationship between cumulative peanut dose to show first objective sign and PCBAT AUC (A) or sIgE to whole peanut (B), Ara h 1 (C) and Ara h 2 (D). Spearman test and R square was calculated and p < .05 were considered significant.